Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.

Severson PL, Tokar EJ, Vrba L, Waalkes MP, Futscher BW.

Epigenetics. 2012 Nov;7(11):1238-48. doi: 10.4161/epi.22163. Epub 2012 Sep 13.

2.

Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation.

Severson PL, Tokar EJ, Vrba L, Waalkes MP, Futscher BW.

Epigenetics. 2013 Oct;8(10):1080-8. doi: 10.4161/epi.25926. Epub 2013 Aug 6.

3.

Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells.

Mahalingaiah PK, Ponnusamy L, Singh KP.

Oncotarget. 2017 Feb 14;8(7):11127-11143. doi: 10.18632/oncotarget.12091.

4.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Review.

5.

Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.

Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP.

Toxicol Appl Pharmacol. 2001 Sep 15;175(3):260-8.

PMID:
11559025
6.

Analysis of aberrant methylation in DNA repair genes during malignant transformation of human bronchial epithelial cells induced by cadmium.

Zhou ZH, Lei YX, Wang CX.

Toxicol Sci. 2012 Feb;125(2):412-7. doi: 10.1093/toxsci/kfr320. Epub 2011 Nov 23.

PMID:
22112500
7.

SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.

García-Tobilla P, Solórzano SR, Salido-Guadarrama I, González-Covarrubias V, Morales-Montor G, Díaz-Otañez CE, Rodríguez-Dorantes M.

Gene. 2016 Nov 30;593(2):292-301. doi: 10.1016/j.gene.2016.08.030. Epub 2016 Aug 26.

PMID:
27570179
8.

Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.

Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, Øyan AM, Kalland KH.

BMC Genomics. 2010 Nov 25;11:669. doi: 10.1186/1471-2164-11-669.

9.

Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells.

Jensen TJ, Novak P, Wnek SM, Gandolfi AJ, Futscher BW.

Toxicol Appl Pharmacol. 2009 Dec 1;241(2):221-9. doi: 10.1016/j.taap.2009.08.019. Epub 2009 Aug 28.

10.

Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.

Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP.

Toxicol Appl Pharmacol. 2005 Aug 15;206(3):288-98. Epub 2005 Jan 18.

PMID:
16039940
11.

Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression.

Kovalchuk O, Tryndyak VP, Montgomery B, Boyko A, Kutanzi K, Zemp F, Warbritton AR, Latendresse JR, Kovalchuk I, Beland FA, Pogribny IP.

Cell Cycle. 2007 Aug 15;6(16):2010-8. Epub 2007 Jun 6.

PMID:
17700064
12.

Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.

Molognoni F, Cruz AT, Meliso FM, Morais AS, Souza CF, Xander P, Bischof JM, Costa FF, Soares MB, Liang G, Jones PA, Jasiulionis MG.

Epigenetics. 2011 Apr;6(4):450-64. Epub 2011 Apr 1.

13.

Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells.

Dudziec E, Gogol-Döring A, Cookson V, Chen W, Catto J.

PLoS One. 2012;7(3):e32750. doi: 10.1371/journal.pone.0032750. Epub 2012 Mar 7.

14.

Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.

Almeida M, Costa VL, Costa NR, Ramalho-Carvalho J, Baptista T, Ribeiro FR, Paulo P, Teixeira MR, Oliveira J, Lothe RA, Lind GE, Henrique R, Jerónimo C.

J Cell Mol Med. 2014 Nov;18(11):2287-97. doi: 10.1111/jcmm.12394. Epub 2014 Sep 11.

16.

Agglomerative epigenetic aberrations are a common event in human breast cancer.

Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW.

Cancer Res. 2008 Oct 15;68(20):8616-25. doi: 10.1158/0008-5472.CAN-08-1419.

17.
18.

Epigenetics in prostate cancer: biologic and clinical relevance.

Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF.

Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22. Review.

PMID:
21719191
19.

Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.

Ribarska T, Ingenwerth M, Goering W, Engers R, Schulz WA.

Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):51-60.

PMID:
20335518
20.

Epigenetic remodeling during arsenical-induced malignant transformation.

Jensen TJ, Novak P, Eblin KE, Gandolfi AJ, Futscher BW.

Carcinogenesis. 2008 Aug;29(8):1500-8. doi: 10.1093/carcin/bgn102. Epub 2008 Apr 30.

Supplemental Content

Support Center